Save your place

Sign in to WhoBought

Please try again later.

Myriad Genetics, Inc. (MYGN) institutional ownership

Market cap$400M SectorHealthcare
Funds holding · Q1 2026
213
reported MYGN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
97 buyers · 116 sellers

Myriad Genetics, Inc. (MYGN) price and institutional activity

Dates

Q1 2026

$0 bought by 97 investors
Acadian Asset Management LLCHrt Financial LP +95 more
$0 sold by 116 investors
BlackRockState Street +114 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Myriad Genetics, Inc. (MYGN) institutional activity · 213

Investor Type Est. change Change Δ Own Date
BlackRock · Reduced
Change −6.4M Date Q1 2026
BlackRock Reduced· Q1 2026 −6.4M Q1 2026
State Street · Reduced
Change −1.5M Date Q1 2026
State Street Reduced· Q1 2026 −1.5M Q1 2026
Acadian Asset Management LLC · Added
Change +1.3M Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +1.3M Q1 2026
Hrt Financial LP · Added
Change +1.3M Date Q1 2026
Hrt Financial LP Added· Q1 2026 +1.3M Q1 2026
Jane Street Group, LLC · Added
Change +1.1M Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +1.1M Q1 2026
Marshall Wace, LLP · Added
Change +1.1M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +1.1M Q1 2026
Glenview Capital Management, LLC · Added
Change +825K Δ Own +18.0% Date Q1 2026
Glenview Capital Management, LLC Added· Q1 2026 +825K +18.0% Q1 2026
Vanguard · Reduced
Change −823K Date Q1 2026
Vanguard Reduced· Q1 2026 −823K Q1 2026
Qube Research & Technologies Ltd · Added
Change +817K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +817K Q1 2026
Walleye Capital LLC · Exited
Change −677K Δ Own −100.0% Date Q1 2026
Walleye Capital LLC Exited· Q1 2026 −677K −100.0% Q1 2026
Federated Hermes, Inc. · Added
Change +666K Date Q1 2026
Federated Hermes, Inc. Added· Q1 2026 +666K Q1 2026
Royce & Associates LP · Exited
Change −605K Δ Own −100.0% Date Q1 2026
Royce & Associates LP Exited· Q1 2026 −605K −100.0% Q1 2026
Dimensional · Reduced
Change −548K Date Q1 2026
Dimensional Reduced· Q1 2026 −548K Q1 2026
Principal Financial Group Inc · Exited
Change −444K Δ Own −100.0% Date Q1 2026
Principal Financial Group Inc Exited· Q1 2026 −444K −100.0% Q1 2026
Morgan Stanley · Reduced
Change −439K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −439K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 213

Famous investor activity in Myriad Genetics, Inc. (MYGN)

Myriad Genetics, Inc. (MYGN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Raha Samraat S. · Director Grant (A) $14K
Price $3.94 Qty 4K Owned 1.1M Trade date Jun 11, 2026 Filed date Jun 12, 2026
Raha Samraat S. Director Grant (A) $3.94 4K $14K 1.1M Jun 11, 2026 Jun 12, 2026
Donnelly Brian J. · Officer Grant (A) $20K
Price $3.94 Qty 5K Owned 573K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Donnelly Brian J. Officer Grant (A) $3.94 5K $20K 573K Jun 11, 2026 Jun 12, 2026
Kumar Rashmi · Director Sell −$67K
Price $4.46 Qty −15K Owned 172K Trade date Jun 8, 2026 Filed date Jun 9, 2026
Kumar Rashmi Director Sell $4.46 −15K −$67K 172K Jun 8, 2026 Jun 9, 2026
Skovronsky Daniel · Director Grant (A) 60K
Owned 196K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Skovronsky Daniel Director Grant (A) 60K 196K Jun 4, 2026 Jun 5, 2026
Newcomer Lee Nisley · Director Grant (A) 60K
Owned 192K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Newcomer Lee Nisley Director Grant (A) 60K 192K Jun 4, 2026 Jun 5, 2026
Davis Mark Steven · Director Grant (A) 60K
Owned 107K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Davis Mark Steven Director Grant (A) 60K 107K Jun 4, 2026 Jun 5, 2026
Phanstiel S. Louise · Director Grant (A) 60K
Owned 342K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Phanstiel S. Louise Director Grant (A) 60K 342K Jun 4, 2026 Jun 5, 2026
Dreismann Heinrich · Director Grant (A) 60K
Owned 231K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Dreismann Heinrich Director Grant (A) 60K 231K Jun 4, 2026 Jun 5, 2026
Reitan Colleen F. · Director Grant (A) 60K
Owned 152K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Reitan Colleen F. Director Grant (A) 60K 152K Jun 4, 2026 Jun 5, 2026
Bisaro Paul · Director Grant (A) 60K
Owned 157K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Bisaro Paul Director Grant (A) 60K 157K Jun 4, 2026 Jun 5, 2026
Kumar Rashmi · Director Grant (A) 60K
Owned 187K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Kumar Rashmi Director Grant (A) 60K 187K Jun 4, 2026 Jun 5, 2026
Jampa Raj · Officer Grant (A) 252K
Owned 252K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Jampa Raj Officer Grant (A) 252K 252K Jun 1, 2026 Jun 2, 2026
Bisaro Paul · Director Buy +$28K
Price $3.69 Qty +8K Owned 97K Trade date May 14, 2026 Filed date May 14, 2026
Bisaro Paul Director Buy $3.69 +8K +$28K 97K May 14, 2026 May 14, 2026
Donnelly Brian J. · Officer Tax withholding or exercise payment (F) -$269K
Price $4.80 Qty -56K Owned 568K Trade date May 1, 2026 Filed date May 4, 2026
Donnelly Brian J. Officer Tax withholding or exercise payment (F) $4.80 -56K -$269K 568K May 1, 2026 May 4, 2026
Verratti Mark · Officer Tax withholding or exercise payment (F) -$5K
Price $4.91 Qty -1K Owned 630K Trade date Apr 14, 2026 Filed date Apr 15, 2026
Verratti Mark Officer Tax withholding or exercise payment (F) $4.91 -1K -$5K 630K Apr 14, 2026 Apr 15, 2026
15 of 61
15 of 61 Sign in to continue to older insider transactions.

Myriad Genetics, Inc. (MYGN) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 14.7M
% of shares outstanding 16.6% Filing date Jan 22, 2024
BlackRock Inc. 14.7M 16.6% Jan 22, 2024
Vanguard Group Inc 10.0M
% of shares outstanding 11.1% Filing date Feb 13, 2024
Vanguard Group Inc 10.0M 11.1% Feb 13, 2024
Camber Capital Management LP 7.6M
% of shares outstanding 8.5% Filing date Feb 14, 2024
Camber Capital Management LP 7.6M 8.5% Feb 14, 2024
Wellington Management Group LLP 7.2M
% of shares outstanding 8.1% Filing date Feb 8, 2024
Wellington Management Group LLP 7.2M 8.1% Feb 8, 2024
Integrated Core Strategies (us) LLC 4.5M
% of shares outstanding 5.0% Filing date May 1, 2024
Integrated Core Strategies (us) LLC 4.5M 5.0% May 1, 2024
State Street Corporation 4.4M
% of shares outstanding 4.7% Filing date May 12, 2026
State Street Corporation 4.4M 4.7% May 12, 2026
Millennium Management LLC 4.3M
% of shares outstanding 4.7% Filing date Mar 18, 2024
Millennium Management LLC 4.3M 4.7% Mar 18, 2024
Earnest Partners LLC 3.3M
% of shares outstanding 4.1% Filing date Jan 9, 2023
Earnest Partners LLC 3.3M 4.1% Jan 9, 2023
8 of 9

Myriad Genetics, Inc. (MYGN) ownership FAQ

Who owns MYGN?

213 reporting institutions disclosed MYGN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.